Figure 1. Follow-up over time of biochemical (LDH, creatininemia, proteinuria [urinary
protein to creatinine ratio, uPCr], soluble urokinase-type plasminogen receptor [uPAR]) and …

Dear Editor, Paroxysmal nocturnal hemoglobinuria (PNH) is a hemolytic disease caused by
the expansion of hematopoietic cells with an acquired somatic mutation in the PIG-A gene …

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell
disorder resulting from the somatic mutation of the X-linked phosphatidylinositolglycan …

Paroxysmal nocturnal haemoglobinuria (PNH) is a clonal acquired haematopoietic stem cell
disorder characterised by a mutation in the PIG-A gene, resulting in deficiency of …

Paroxysmal nocturnal hemoglobinuria (PNH), a rare hematological condition, presents with
hemolytic or thrombotic symptoms. PNH stem cells arise due to somatic mutations in the …

Background Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disorder due to
GPI anchored proteins deficiency on blood cells surface, resulting in complement activation …

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare disease characterized by chronic
intravascular hemolysis and a highly increased risk for thrombosis. A mutation of the …

Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is caused by a somatic mutation in
the PIG‐A gene, which encodes for glycosylphosphatidylinositol, a phospholipid membrane …

Paroxysmal Nocturnal Hemoglobinuria (PNH) is characterized by chronic intravascular
hemolysis and a high risk of thrombosis, on a background of variable pancytopenia. The …

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder caused by the
expansion of a hematopoietic clone harboring a somatic genetic variant in the PIG-A gene …